Atlas Trials

The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects

Clinical trial NCT03943251 · COMPLETED

Trial details

NCT number
NCT03943251
Sponsor
Sunshine Lake Pharma Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy
Start date
2019-07-04
Primary completion
2019-12-11
Enrollment
69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.